HPTN 083 data from AIDS 2020: Virtual on long-acting injectable cabotegravir vs daily TDF/FTC for PrEP in MSM and transgender women, reported by CCO
Expert discussion of data from CROI 2020 on new and established treatment of HIV from Drs. Roger Bedimo and Joseph Eron, provided by CCO
Watch this video module from CCO to learn key strategies for individualizing ART management based on regimen safety and tolerability considerations
Download free expert-authored slides reviewing ART management recommendations for specific patient populations and key data on safety and tolerability
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.